載入...
The development of proteinase-activated receptor-2 modulators and the challenges involved
Protease-activated receptor-2 (PAR2) has been extensively studied since its discovery in the mid-1990. Despite the advances in understanding PAR2 pharmacology, it has taken almost 25 years for the first inhibitor to reach clinical trials, and so far, no PAR2 antagonist has been approved for human us...
Na minha lista:
| 發表在: | Biochem Soc Trans |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Portland Press Ltd.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752072/ https://ncbi.nlm.nih.gov/pubmed/33242065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BST20200191 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|